Nasal high flow oxygen therapy in patients with COPD reduces respiratory rate and tissue carbon dioxide while increasing tidal and end-expiratory lung volumes: a randomised crossover trial

Overview of attention for article published in Thorax, March 2016

Altmetric Badge

About this Attention Score

In the top 5% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (95th percentile)
High Attention Score compared to outputs of the same age and source (97th percentile)

Mentioned by

news: 1 news outlet
policy: 2 policy sources

twitter: 52 X users
facebook: 4 Facebook pages

Citations

dimensions_citation: 180 Dimensions

Readers on

mendeley: 214 Mendeley

Summary News Policy documents X Facebook Dimensions citations

So far, Altmetric has seen 2 policy documents that reference this research output.

Endobronchial Valves for the Treatment of Severe Emphysema

Cited by Canadian Agency for Drugs and Technologies in Health on 29 Oct 2019

CADTH is an independent, not-for-profit organization responsible for providing health care decision-makers with objective evidence to help make informed decisions about the optimal use of health technologies.

myAIRVO2 for the treatment of chronic obstructive pulmonary disease

Cited by National Institute for Health and Care Excellence on 01 Oct 2018

The National Institute for Health and Care Excellence (NICE) in the UK provides national guidance and advice to improve health and social care.

This page shows the most recent policy documents that mention this research output.

Click here to find out how to access more activity.